Background. The identification of hibernating myocardium is important in selecting patients who will benefit from coronary revascularization. This study was performed to determine whether dobutamine stress echocardiography (DSE) could identify hibernating myocardium and predict improvement in regional systolic wall thickening after revascularization.
T he term hibernating myocardium was first used by Rahimtoola1 to describe left ventricular dysfunction resulting from chronic myocardial ischemia and demonstrating recovery of function after coronary revascularization. Several lines of evidence support the concept that hibernating myocardium is clinically important. First, coronary revascularization may lead to improved regional and global left ventricular function,2-8 even in patients with symptoms of left ventricular dysfunction rather than angina.9-11 Second, Nesto et a112 have shown that patients with depressed left ventricular function who manifested significant improvement in preoperative ejection fraction with inotropic stimulation or a premature ventricular contraction have improved long-term survival compared with those lacking contractile reserve. Finally, several studies have shown that the ability to identify contractile reserve in patients with depressed left ventricular function has important prognostic implications in patients being considered for coronary bypass surgery. [13] [14] [15] [16] [17] Positron emission tomography and`'1Tl imaging have been used to identify myocardial viability. 18 Regional wall thickening score was determined at rest and during each level of dobutamine infusion. It was determined before the study that significant improvement in regional systolic wall thickening during dobutamine infusion (contractile reserve) would be defined by the presence of the following two criteria: (1) improved systolic wall thickening grade in at least two adjacent abnormal segments and (2) a reduction in regional wall thickening score sufficient in magnitude to ascertain improved regional left ventricular function at a 95% confidence level. The former criterion was chosen to minimize the potential influence of tethering of an abnormal segment by adjacent normal or hyperkinetic segments. The latter criterion was determined by assessing interobserver and intraobserver differences in regional wall thickening score in the first 20 patients studied. Each of these studies was read in blinded fashion by two experienced observers. The primary observer reinterpreted the studies 4 weeks after his initial reading. Linear regression analysis was used to compare regional wall thickening score between observers. A correlation coefficent of >0.98 and a coefficient of variation of 10% was present for both interobserver and intraobserver variation. Thus, a 20% reduction in wall motion score represents the 95% confidence level for detecting a significant difference between resting and stress images in our laboratory. By these criteria, contractile reserve was considered to be present if the patient manifested improved regional systolic wall thickening at any dose of dobutamine, even if subsequent doses were associated with worsening of wall thickening caused by ischemia. Fig 1 shows The present study was not designed with mortality as an end point. However, eight patients in the study died over a follow-up period ranging from 3 to 6 months. All deaths were cardiac in origin, and all occurred in patients without contractile reserve by dobutamine stress echocardiography. Three deaths occurred in patients receiving medical therapy, all of whom had severely depressed left ventricular function and were considered inoperable. There were three perioperative deaths caused by pump failure, and two other patients underwent bypass surgery and later died of congestive heart failure. Although lack of contractile reserve on dobutamine stress echocardiography was significantly associated with increased cardiac mortality (x2=5.72, P=.017), it cannot be determined whether this effect is independent of resting left ventricular function. Thus, although the apparent increase in mortality in patients without contractile reserve supports the prognostic findings of Nesto et al,12 a large prospective clinical trial is needed to determine whether dobutamine stress echocardiography can predict mortality in patients undergoing revascularization.
The major finding of this study is that echocardiographic detection of contractile reserve during low-dose dobutamine infusion is a strong predictor of recovery of left ventricular function after coronary revascularization. Ventriculography has been used to detect contractile reserve12, 35-37; Quantitative regional wall motion analysis was not used for several reasons. First, quantitative techniques require stop-frame analysis of the videotaped echocardiograms, which results in loss of 50% of the image. Second, manual tracing of the endocardial and epicar-dial contours is required, thus adding a subjective component to the "quantitative" methods. This is particularly troublesome if endocardial dropout is present over a portion of the image. Finally, quantitative techniques that analyze only end-diastolic and end-systolic frames lack the temporal resolution to examine early systolic thickening and therefore may be more subject to the effects of cardiac translation and/or tethering. Because of these considerations, we used the semiquantitative method of assessing regional wall thickening that has been recommended by the American Society of Echocardiography.26 Given the reproducibility of this method43 and the fact that the images were interpreted in blinded fashion, it is unlikely that the results would have been enhanced by application of quantitative methods.
Conclusions
Dobutamine stress echocardiography is a simple, cost-effective, and widely available method of identifying hibernating myocardium and predicting recovery of left ventricular function after coronary revascularization. This technique promises to be clinically valuable in the selection of patients for coronary revascularization.
